HL Science Acquires Patent Rights for Metabolic Syndrome Prevention
[Asia Economy Reporter Junho Hwang] HL Science announced on the 11th that it has acquired a Taiwanese patent for a composition for the prevention, improvement, and treatment of obesity and/or metabolic syndrome accompanied by diabetes, containing an IB complex as an active ingredient.
Hot Picks Today
"Parents Deposited 10 Million Won for Me"... Se...
- Iranian Dissident Media: Hardline Faction Divided Over Ceasefire Talks With US
- "SK Hynix Stock Windfall"... Teenager With Wads of Cash Turns Thief at Jewelry S...
- "Major Crash Is Coming... Buy Even If You Have to Skip a Meal" 'Rich Dad' Shares...
- "Save 30 Million Won, Grow It to 100 Million": Dramatic Pledge Sparks "Is This a...
The company explained, "The IB complex in this patent inhibits the enzymatic activity of pancreatic lipase, thereby hindering the digestion and absorption of ingested fats, suppressing fat synthesis, promoting fat breakdown, and regulating energy metabolism."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
